Skip to main content

Nonprofit · EIN 84-2460457

INSTITUTE FOR GENE AND CELL THERAPIES

Tax-exempt · WASHINGTON, DC 20004

Financials

$1.4M$1.2M2023$1.1M$1.2M2024
Revenue Expenses · by fiscal year end
Financials of INSTITUTE FOR GENE AND CELL THERAPIES by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$1,093,387$1,207,387-$114,000$875,245$395,007$480,238
December 31, 2023990$1,400,439$1,158,630$241,809$846,401$252,163$594,238
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$1,093,333
Membership dues
$1,093,333
Program service revenue
$0
Investment income
$54
Other revenue
$0

Expenses

Grants and similar amounts paid
$0
Salaries, compensation and benefits (total)
$0
Professional fundraising fees
$0
Legal fees
$5,655
Accounting fees
$15,966
Program services (functional)
$1,173,205
Management and general (functional)
$34,182

Balance sheet and other

Total assets, start of year
$846,401
Total assets, end of year
$875,245
Total liabilities, end of year
$395,007
Net assets, end of year
$480,238
Gross receipts
$1,093,387
Employees
0
Volunteers
3
Year formed
2019
State of legal domicile
DC

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensation
ERIK PAULSENCHAIRMAN
Trustee or director, Officer
1$0
MICHAEL CAPALDIPRESIDENT
Trustee or director, Officer
2$0
KENNETH HODGESECRETARY
Trustee or director, Officer
1$0
CHRISTOPHER MAYTREASURER
Trustee or director, Officer
1$0
990 for the year ended December 31, 2023: 4 people
NameTitleHours / weekCompensation
ERIK PAULSENCHAIRMAN
Trustee or director, Officer
1$0
MICHAEL CAPALDIPRESIDENT
Trustee or director, Officer
2$0
KENNETH HODGESECRETARY
Trustee or director, Officer
10$0
CHRISTOPHER MAYTREASURER
Trustee or director, Officer
2$0

Address and contacts

Address (IRS master file)
909 E STREET NW 2ND FL, WASHINGTON, DC 20004-2036
Principal officer (990 for 2024)
MICHAEL CAPALDI, 909 E STREET NW 2ND FL, WASHINGTON, DC 20004
Signed the 990
MICHAEL CAPALDI, EXECUTIVE DIRECTOR
Phone
(985) 707-9104
Return prepared by
HELFER AND COMPANY LLC

Mission

IGT AIMS TO EDUCATE POLICY MAKERS, MEDIA, PATIENTS AND HEALTH CARE PROVIDERS ABOUT THE SCIENCE OF GENE AND CELL THERAPIES, ADVOCATE FOR A MODERNIZED REGULATORY FRAMEWORK THAT ENCOURAGES CURATIVE INNOVATIONS, PROMOTES PATIENT ACCESS, AND CODIFIES TRANSPARENT REIMBURSEMENT PRACTICES FOR THE BETTERMENT OF PATIENTS, FAMILIES AND CAREGIVERS WITH RARE AND COMPLEX MEDICAL CONDITIONS.

990 for the year ended December 31, 2024

Program accomplishments

  • IGT ADVOCATES FOR A MODERNIZED REGULATORY AND REIMBURSEMENT FRAMEWORK THAT ENCOURAGES THE DEVELOPMENT OF TRANSFORMATIVE GENE THERAPIES AND PROMOTES PATIENT ACCESS.
    Expenses $1,173,205

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
84-2460457
Tax-exempt status
501(c)(4): Social welfare organization
Donations deductible
No
Exempt since
2020
Accounting year ends
December
Files
Form 990 or 990-EZ
Category (NTEE)
Medical research (H92)
Assets (IRS master file)
$875,245
Income (IRS master file)
$1,093,387

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$1,093,387$1,207,387$875,245XML
990December 2023$1,400,439$1,158,630$846,401XML
990December 2022$1,325,000$1,103,289$538,185IRS
990December 2021–––IRS
990December 2020–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 84-2460457).

Questions about INSTITUTE FOR GENE AND CELL THERAPIES

What is the EIN of INSTITUTE FOR GENE AND CELL THERAPIES?
The employer identification number (EIN) of INSTITUTE FOR GENE AND CELL THERAPIES is 84-2460457.
Is INSTITUTE FOR GENE AND CELL THERAPIES tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(4) since 2020.
Are donations to INSTITUTE FOR GENE AND CELL THERAPIES tax-deductible?
No. The IRS master file says contributions to it are not deductible.
Which annual return does INSTITUTE FOR GENE AND CELL THERAPIES file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of INSTITUTE FOR GENE AND CELL THERAPIES due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did INSTITUTE FOR GENE AND CELL THERAPIES last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of INSTITUTE FOR GENE AND CELL THERAPIES?
The 990 for the year ended December 31, 2024 names MICHAEL CAPALDI.
Who are the officers and directors of INSTITUTE FOR GENE AND CELL THERAPIES?
The 990 for the year ended December 31, 2024 lists 4 people; 0 received compensation from the organization.
How much revenue does INSTITUTE FOR GENE AND CELL THERAPIES have?
On its 990 for the year ended December 31, 2024 it reported revenue of $1,093,387, expenses of $1,207,387 and total assets of $875,245 at year end.

Other nonprofits in WASHINGTON

All nonprofits in WASHINGTON · District of Columbia · Medical research